Nine varieties of traditional Chinese medicine are approved as the first second level protected varieties of traditional Chinese Medicine
-
Last Update: 2016-07-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On July 22, CFDA official website released the notice of protected varieties of traditional Chinese medicine According to the regulations on the protection of traditional Chinese medicine varieties, it is approved by the State Food and drug administration Salvianolic acid for injection of Tianjin Tianshili Zhijiao Pharmaceutical Co., Ltd., puyuanhewei capsule of Qingdao Huaren Taiyi Pharmaceutical Co., Ltd., erxieting granules of Hefei Huarun shenlu Pharmaceutical Co., Ltd., pulingpenyankang granules of Xiangyu Pharmaceutical Co., Ltd., Xuesaitong (freeze-dried) for injection of Harbin Zhenbao Pharmaceutical Co., Ltd., compound Huangbai liquid coating of Shandong Hanfang Pharmaceutical Co., Ltd , Fuzheng Huayu capsule of Shanghai Huanghai Pharmaceutical Co., Ltd., xuanfeizhisou mixture of Gansu Pu'an Pharmaceutical Co., Ltd., Xuesaitong (freeze-dried) for injection of Kunming Pharmaceutical Group Co., Ltd and Shengxuebao mixture of Qinghua dehen Xi'an Xingfu Pharmaceutical Co., Ltd are the first two-level protected varieties of traditional Chinese medicine, with a protection period of seven years from the date of announcement Enterprises of the same variety shall apply for the protection of the same variety in accordance with the regulations on the protection of traditional Chinese medicine varieties and relevant regulations If they fail to do so within the time limit, they shall stop production If they continue to produce, the State Food and Drug Administration will suspend the validity of their approval number and investigate and deal with them in accordance with the relevant provisions of Article 23 of the regulations on the protection of traditional Chinese medicine varieties In addition, the protection period of the aerosol produced by Shenyang Hongyao Jingcheng Pharmaceutical Co., Ltd was extended.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.